Humanigen

Humanigen Market Cap per Employee

Delisted

The Market Cap per Employee of Humanigen (HGENQ) as of Nov 20, 2026 is 11.90 USD. In the previous year, Market Cap per Employee was 11.90 USD — a change of 0.00% (lower).

Market Cap per Employee

11.90USD

YoY

0.00%

Last updated:

Market Cap per Employee of Humanigen is 2022 11.90 USD. Market Cap per Employee of Humanigen was 2021 11.90 USD. It decreases by 0.00% lower compared to the previous year.

The Humanigen Market Cap per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Market Cap per Employee
Date
Market Cap per Employee
Jan 1, 2015
11.90 USD
Jan 1, 2016
11.90 USD
Jan 1, 2017
11.90 USD
Jan 1, 2018
11.90 USD
Jan 1, 2019
11.90 USD
Jan 1, 2020
11.90 USD
Jan 1, 2021
11.90 USD
Jan 1, 2022
11.90 USD
The Humanigen Market Cap per Employee history
YEARMarket Cap per EmployeeYoY
11.90USD0.00%
11.90USD0.00%
11.90USD0.00%
11.90USD0.00%
11.90USD0.00%
11.90USD0.00%
11.90USD0.00%
11.90USD0.00%
11.90USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Humanigen Stock analysis

What does Humanigen do? Humanigen Inc is a pharmaceutical company specializing in the discovery, development, and marketing of drugs, therapies, and solutions in the field of medical research. The company was originally founded in 2000 and is headquartered in Burlingame, California. One major focus of Humanigen Inc is the treatment of severe and life-threatening diseases such as cancer or HIV/AIDS that have not been sufficiently addressed by other medications. The company has developed a range of special technologies that enable it to develop innovative and effective therapies and drugs. An important aspect of Humanigen Inc's business model is collaboration with other companies, institutions, and research facilities worldwide. Through partnerships and cooperation, the company is able to cover the entire spectrum of research and development, allowing it to develop treatment options even faster and more effectively. Humanigen Inc has several different divisions and products designed for various applications. An important subsidiary of the company is the Humanigen Center for HIV Cure Research, which specifically focuses on combating HIV. There, the company works closely with scientists, researchers, and partners to develop new and innovative treatment options. Another important product of Humanigen Inc is the drug Lenzilumab. Lenzilumab is an antibody used to treat severe and life-threatening diseases such as cancer and COVID-19. Lenzilumab has shown great promise in clinical trials and could be the key to developing new and effective treatment options. In addition, Humanigen Inc has filed a variety of patents that enable it to develop new and innovative technologies in medical research. Many of these technologies are also licensed by other companies and research institutions, promoting the growth and expansion of Humanigen Inc. In recent years, the company has also placed a major focus on the field of digital technology. By utilizing big data, artificial intelligence, and other digital technologies, Humanigen Inc is able to develop new therapy options even faster and more effectively, catering specifically to the needs of patients and doctors. Overall, Humanigen Inc is an innovative and rapidly growing company focused on the development of new and effective treatment options for serious diseases. Through collaboration with other companies and institutions, the development of new technologies, and a targeted focus on the needs of patients and doctors, the company is able to respond even faster and more effectively to challenges in the field of medical research. Humanigen is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Humanigen stock

Market Cap per Employee of Humanigen is 11.90 USD in 2022.

Market Cap per Employee of Humanigen changed from 11.90 USD to 11.90 USD, representing a 0.00% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Market Cap per Employee Humanigen since 2006 – with annual values, charts, and detailed analysis.

Market cap per employee shows the market value attributed to each employee. Technology companies typically have higher values due to intellectual capital.

Market Cap per Employee's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Market Cap per Employee's Humanigen historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Workforce — Humanigen

All Key Metrics — Humanigen